ResearcherUniversity of ArizonaActive in the last 2 years

Nam Y Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3730-0774; OpenAlex author ID A5012601024; NIH RePORTER profile ID 2047139. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2026: 2 papers, 1 grant

Papers 2

An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.neo.2026.101379 ↗
Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. Co-author DOI 10.3390/md24060201 ↗

Grants 1

Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer R01CA275036 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christopher Cartmell · 2 shared papers, 2026 · strength 0.53
- Paper An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma. DOI 10.1016/j.neo.2026.101379 ↗
- Paper Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. DOI 10.3390/md24060201 ↗
Nathan A. Ellis · 1 shared paper, 2026 · strength 0.28
- Paper An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma. DOI 10.1016/j.neo.2026.101379 ↗
Hannah R. Ortiz · 1 shared paper, 2026 · strength 0.28
- Paper An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma. DOI 10.1016/j.neo.2026.101379 ↗
Caleb A. Seekins · 1 shared paper, 2026 · strength 0.26
- Paper Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. DOI 10.3390/md24060201 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.